Case Study
Removing Barriers, Restoring Hope: Transforming Access to Immunotherapy with IQVIA Patient Engagement and Support
Oct 14, 2025
Access to immunotherapy can be transformative for patients with cancer, yet financial and logistical barriers often prevent timely treatment. In partnership with a leading pharmaceutical company, IQVIA launched a Patient Access Program (PAP) to ensure eligible patients could begin and maintain their immunotherapy regimens without delay or disruption.

Related solutions

Contact Us